Total raised
—
Stage
Pre-Funding
Founded
2002
Headcount
1-10
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
Semorex Technologies has discovered molecular compounds that exhibit potent and selective anticancer activity against solid tumors and hematological malignancies. The company is interested in using these compounds, which were found to be nontoxic in mice models, to develop anticancer therapies. Semorex has also developed a diagnostic approach for the rapid and reliable diagnosis of systemic/invasive fungal infection (SFI/IFI). The companys method offers quick and appropriate treatment for patients with fungal infections while ruling out SFI/IFI in individuals suffering from other disease states causing similar symptoms. Semorex Technologies Ltd is an R&D subsidiary of Semorex Inc.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & ScreeningDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
medical-technologiesdiagnosticshealthcare-providerspharma-companiesoncologytherapeuticscancerinfectionnanotechnologydrug-delivery